Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Galantamine and CBT	28
Overall Study	STARTED	Galantamine Only	27
Overall Study	STARTED	Placebo and CBT	38
Overall Study	STARTED	Placebo Only	27
Overall Study	COMPLETED	Galantamine and CBT	20
Overall Study	COMPLETED	Galantamine Only	20
Overall Study	COMPLETED	Placebo and CBT	27
Overall Study	COMPLETED	Placebo Only	25
Overall Study	NOT COMPLETED	Galantamine and CBT	8
Overall Study	NOT COMPLETED	Galantamine Only	7
Overall Study	NOT COMPLETED	Placebo and CBT	11
Overall Study	NOT COMPLETED	Placebo Only	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00809835/flow